Scott Vandermeer
Fondatore presso Infusion 51A LP
Posizioni attive di Scott Vandermeer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Infusion 51A LP | Fondatore | 01/04/2015 | - |
| Corporate Officer/Principal | 01/04/2015 | - | |
| International Infusion LP | Direttore Finanziario/CFO | 01/04/2011 | - |
Vivacitas Oncology, Inc.
 Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Vivacitas Oncology, Inc. is a private clinical stage biopharmaceutical company founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a, LP. The company is based in Walnut Creek, CA. Vivacitas Oncology is focused on combating cancers that have proven to be resistant to current treatment modalities. The company aims to improve upon well-known chemotherapies with demonstrated effect, but which also possess challenges with potency, toxicity, stability, and other issues limiting their use. The CEO is Mark J. Suseck. | Direttore/Membro del Consiglio | - | - |
| Direttore Finanziario/CFO | - | - | |
| Fondatore | 01/01/2015 | - |
Storia della carriera di Scott Vandermeer
Precedenti posizioni note di Scott Vandermeer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AVANT DIAGNOSTICS INC | Amministratore Delegato | 11/12/2017 | - |
| Direttore Finanziario/CFO | 11/12/2017 | 01/01/2020 |
Formazione di Scott Vandermeer
| University of Illinois | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| 2 |
Posizioni
| Director of Finance/CFO | 3 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Settori
| Miscellaneous | 2 |
| Consumer Services | 2 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
| Infusion 51A LP | Miscellaneous |
| International Infusion LP | |
Vivacitas Oncology, Inc.
Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Vivacitas Oncology, Inc. is a private clinical stage biopharmaceutical company founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a, LP. The company is based in Walnut Creek, CA. Vivacitas Oncology is focused on combating cancers that have proven to be resistant to current treatment modalities. The company aims to improve upon well-known chemotherapies with demonstrated effect, but which also possess challenges with potency, toxicity, stability, and other issues limiting their use. The CEO is Mark J. Suseck. | Health Services |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Borsa valori
- Insiders
- Scott Vandermeer
- Esperienza
